Save the date
Save the dateApril 23, 2024 to August 30, 2024GMT+8
Organizer
Organizer
Organizer:
Contact Person: YUHONG LIN
Introduction
Introduction

中国美国商会医疗组是商会重要的行业工作组之一,包括一百多家医疗会员企业,业务细分领域涵盖生物制药、医药器械、医疗服务等等。商会医疗组企业每年积极参与商会白皮书的撰写,并且在地方省市等拜会活动中向政府部门积极献言献策,为中美两国在医疗领域深化交流合作奠定了良好的基调和氛围。 在此背景下,商会推出了《白皮书》特别版——《2024年美国企业在中国·医疗行业白皮书》(以下简称《卫生健康行业白皮书》)。《卫生健康行业白皮书》全面分析了中国实施的医疗相关政策和举措及其对在华运营的外商投资企业的影响,同时为两国政府提供全面的建设性建议,期待借此增进双方的相互理解,帮助会员企业成功解决存在的问题。


The Healthcare Industry Group is one of the largest and most active industries of AmCham China, including more than 100 member companies, with segments covering biopharmaceuticals, medical devices, medical services, etc. The member companies in the Healthcare Industry Group participate in AmCham China's annual White Paper projects each year, and provide suggestions to government departments during delegation visits, laying a good foundation for deepening cooperation in the healthcare sector between the two nations.


In this context, AmCham China has launched a special edition of the White Paper - "2024 American Business in China: Healthcare Industry White Paper" (referred to as the "Health Industry White Paper"). The Healthcare White Paper comprehensively analyzes the healthcare-related policies and measures implemented in China and their impact on global companies' business in China. Also, it provides constructive suggestions for the governments of both countries, hoping to enhance mutual understanding and help member companies successfully solve problems.

Main Contents of This Year
Main Contents of This Year
Price
Price

Hard Copy-Member Price

Member Price RMB 480

Hard Copy-Non Member Price

RMB 800